missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CX3CL1/Fractalkine Chemokine Domain Biotinylated Antibody, R&D Systems™
Mouse Monoclonal Antibody has been used in 5 publications
Brand: R&D Systems BAM365
This item is not returnable.
View return policy
Description
CX3CL1/Fractalkine Monoclonal specifically detects CX3CL1/Fractalkine in Human samples. It is validated for Western Blot, ELISA Detection (Matched Antibody Pair).
Specifications
| CX3CL1/Fractalkine | |
| Monoclonal | |
| LYOPH | |
| Western Blot 1 ug/mL, ELISA Detection (Matched Antibody Pair) 0.5-2.0 ug/mL | |
| P78423 | |
| CX3CL1 | |
| NS0-derived and E.coli-derived Recombinant Human Fractalkine Gln25-Arg339 Accession # P78423 | |
| 100 μg | |
| Primary | |
| Detects human CX3CL1 in ELISAs and Western blots. In ELISAs, this antibody shows approximately 8% cross-reactivity with recombinant mouse (rm) CXCL6 and less than 0.2% cross-reactivity with rhCXCL6, rhCXCL9, and rrCX3CL1. | |
| Human | |
| Purified |
| Western Blot, ELISA | |
| 51637 | |
| Biotin | |
| Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. with No Preservative | |
| ABCD-3, C3Xkine, chemokine (C-X3-C motif) ligand 1, CX3C membrane-anchored chemokine, CXC3, CXC3C, FKN, fractalkine, Neurotactin, neurotactin), NTNsmall inducible cytokine subfamily D (Cys-X3-Cys), member 1 (fractalkine, NTTSmall-inducible cytokine D1, SCYD1C-X3-C motif chemokine 1, small inducible cytokine subfamily D (Cys-X3-Cys), member-1 | |
| Mouse | |
| Protein A or G purified from ascites | |
| RUO | |
| 6376 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction